| 0 (0%) | 12-27 00:25 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 80.39 | 1-year : | 93.9 |
| Resists | First : | 68.83 | Second : | 80.39 |
| Pivot price | 64.84 |
|||
| Supports | First : | 58.92 |
Second : | 52.79 |
| MAs | MA(5) : | 66.76 |
MA(20) : | 63.54 |
| MA(100) : | 56.27  |
MA(250) : | 0 | |
| MACD | MACD : | 2.6 |
Signal : | 2.5 |
| %K %D | K(14,3) : | 76.8 |
D(3) : | 81.3 |
| RSI | RSI(14): 65.6 |
|||
| 52-week | High : | 111.29 | Low : | 47.25 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ LNTH ] has closed below upper band by 28.6%. Bollinger Bands are 16.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 66.97 - 67.22 | 67.22 - 67.42 |
| Low: | 65.52 - 65.84 | 65.84 - 66.09 |
| Close: | 66.24 - 66.72 | 66.72 - 67.11 |
Fri, 26 Dec 2025
Truist sees upside in Lantheus Holdings, Inc. (LNTH) despite PYLARIFY pressure - MSN
Wed, 24 Dec 2025
Assessing Lantheus (LNTH) Valuation After Earnings Beat, Raised Guidance and Radiopharma Strategy Confidence - simplywall.st
Sun, 21 Dec 2025
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3 - Yahoo Finance
Sat, 13 Dec 2025
Lantheus (LNTH) Valuation Revisited After Truist Upgrade on Double-Digit Growth Potential - Yahoo Finance
Thu, 11 Dec 2025
Preclinical Evaluation of 64Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging - Journal of Nuclear Medicine
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 66 (M) |
| Shares Float | 61 (M) |
| Held by Insiders | 2.3 (%) |
| Held by Institutions | 110.9 (%) |
| Shares Short | 7,080 (K) |
| Shares Short P.Month | 7,100 (K) |
| EPS | 2.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.87 |
| Profit Margin | 10.9 % |
| Operating Margin | 11.3 % |
| Return on Assets (ttm) | 9.9 % |
| Return on Equity (ttm) | 14.5 % |
| Qtrly Rev. Growth | 1.3 % |
| Gross Profit (p.s.) | 14.32 |
| Sales Per Share | 23.07 |
| EBITDA (p.s.) | 6.15 |
| Qtrly Earnings Growth | -77.1 % |
| Operating Cash Flow | 458 (M) |
| Levered Free Cash Flow | 327 (M) |
| PE Ratio | 27.68 |
| PEG Ratio | 0 |
| Price to Book value | 3.95 |
| Price to Sales | 2.89 |
| Price to Cash Flow | 9.66 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|